Assessment Of The Effects Of Short and Long Term Use Of CPAP

NCT00592631 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2016-02-10

Study results available
· View outcomes & findings →

Summary

We hypothesize that the nocturnal use of continuous positive airway pressure in adults and children with asthma will decrease airway reactivity.

Conditions

Interventions

DEVICE

CPAP-Continuous Positive Airway Pressure

Cpap will be worn at night by subjects 6 to 7 days duration.

DEVICE

SHAM

SHAM will be worn at night by subjects 6 to 7 days duration.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Robert S. Tepper, MD, PhD · Indiana University

  • Mike Busk, MD · NIFS/ Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592631 on ClinicalTrials.gov